Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Creo Medical Limited

Creo Medical is involved in the development and application of advanced energy technology for surgical endoscopy, focusing on improving patient outcomes through innovative healthcare solutions.

Metric
Company Name	Creo Medical Limited
Symbol	CREO
MSH ID	COM:CREOMEDICAL
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	GB
Stage
Employee Count	287
Website	creomedical.com
LinkedIn
Founders

Metric
Market Cap	1.52M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	39.25M
Revenue (LTM)
Revenue (NTM)
Gross Profit	15.16M
EBITDA	-27.78M
Operating Income	-32.11M
Net Income	-27.65M
EPS	-0.09
Diluted EPS	-0.09
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.50
Operating Profit Margin	-0.81
EBITDA Margin	-0.71
Net Profit Margin	-0.70
Return on Equity	-0.34
Return on Assets	-0.28
Return on Capital Employed	-0.37

CREO

COM:CREOMEDICAL

Creo Medical

Last Close

16.63

25/11 09:13

Market Cap

1.19M

Beta: -

Volume Today

90.69K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-2.91
P/B Ratio	1.59
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.52
EV Multiple	-3.09

Metric
Days Sales Outstanding
Days Payables Outstanding	233.86
Days Inventory Outstanding	202.78
Operating Cycle	339.91
Cash Conversion Cycle	193.21
Asset Turnover	0.44

Metric
Operating Cash Flow	-26.63M
Free Cash Flow	-28.67M
Cash Flow to Debt	-1.42
Operating Cash Flow/Sales	-0.66
Free Cash Flow Yield	-0.19

Metric
Cash & Equivalents	3.82M
Accounts Receivable	-1.78M
Inventory	10.32M
Goodwill	24.34M
Debt to Capitalization	0.23
Debt to Assets	0.16
Current Ratio	1.93
Quick Ratio	3.45

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.05
R&D to Revenue
SG&A to Revenue	1.62